Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COREG-MR vs TOPROL-XL on Lipid Profile in Hypertension
NCT00273052Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of carvedilol in hypertension (HTN) (2 arms), sponsored by GSK. Primary endpoints: Change From Baseline in Triglycerides Levels at Month 6 and Change From Baseline in High-Density Lipoprotein Cholesterol Levels at Month 6. Started Jan 2006; status: completed.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00273052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273052.